Covered recipient · General Payments record
CEREN KARAALI
General Payments · PY2025
$1,032.32
- Reported across 13 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $832.38 | 11 |
| Education | $199.94 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $219.65 | 2 |
| GENZYME CORPORATION | $152.27 | 2 |
| JAZZ PHARMACEUTICALS INC. | $132.30 | 1 |
| Daiichi Sankyo Inc. | $107.98 | 1 |
| PharmaEssentia USA Corporation | $107.10 | 1 |
| Regeneron Healthcare Solutions, Inc. | $100.00 | 1 |
| Alexion Pharmaceuticals, Inc. | $99.99 | 1 |
| SOBI, INC | $34.20 | 1 |
| Geron Corporation | $30.06 | 1 |
| Astellas Pharma US Inc | $24.96 | 1 |
| Syndax Pharmaceuticals, Inc. | $23.81 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $1,032.32 | 13 |
Payment records · PY2025 (13)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $99.99 | 10/15/2025 | Education | Undisputed | 06/30/2026 | 1211399094 | CMS |
| Astellas Pharma US Inc | $24.96 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238930233 | CMS |
| Daiichi Sankyo Inc. | $107.98 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197006305 | CMS |
| Exelixis Inc. | $119.70 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218792429 | CMS |
| Exelixis Inc. | $99.95 | 08/28/2025 | Education | Undisputed | 06/30/2026 | 1218792427 | CMS |
| GENZYME CORPORATION | $137.13 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233277257 | CMS |
| GENZYME CORPORATION | $15.14 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233277275 | CMS |
| Geron Corporation | $30.06 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238889762 | CMS |
| JAZZ PHARMACEUTICALS INC. | $132.30 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234305578 | CMS |
| PharmaEssentia USA Corporation | $107.10 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246831967 | CMS |
| Regeneron Healthcare Solutions, Inc. | $100.00 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212955940 | CMS |
| SOBI, INC | $34.20 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240257276 | CMS |
| Syndax Pharmaceuticals, Inc. | $23.81 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238992058 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.